Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Scientists develop computational method to map cancer progression

A team of scientists has developed a computational method to map cancer progression, an advance that offers new insights into the factors that spur this affliction as well as new ways of selecting effective therapies.

28 Jun 2016

Vitamin D sufficiency linked to better pancreatic cancer survival

Survival is improved in pancreatic cancer patients with sufficient versus deficient plasma levels of 25-hydroxyvitamin D, as assessed prior to diagnosis.

28 Jun 2016

High levels of zinc may lead to kidney stone formation

David Killilea, PhD, a staff scientist at Children's Hospital Oakland Research Institute- the research arm of UCSF Benioff Children's Hospital Oakland - co-authored a study into the causes of kidney stones.

28 Jun 2016

New non-invasive method may help treat people with inoperable or hard-to-reach tumors

Matthew Gdovin, an associate professor in the UTSA Department of Biology, has developed a newly patented method to kill cancer cells.

28 Jun 2016

Cisplatin-based chemotherapy may lead to hearing loss in many testicular cancer survivors

Many testicular cancer survivors experience hearing loss after cisplatin-based chemotherapy, according to researchers at Indiana University.

28 Jun 2016

Prognostic factor could help identify tumor recurrence after surgery for prostate cancer

Slightly more than 10% of all patients who undergo successful surgery for prostate cancer have an elevated risk of tumor recurrence afterwards - especially as metastases.

27 Jun 2016

NYU Lutheran helps patients fight prostate cancer with latest diagnostic and robotic surgery technology

Leading NYU Lutheran's fight is Marc Bjurlin, DO, the hospital's newly appointed director of urologic oncology and clinical assistant professor of urology at NYU School of Medicine.

27 Jun 2016

Study highlights need to improve end-of-life care for all patients with serious illnesses

Historically, efforts to improve end-of-life care have focused primarily on patients with cancer. But few studies have looked at the quality of end-of-life care for patients with other serious illnesses, such as lung, kidney or heart failure or dementia.

27 Jun 2016

Vice President Biden to host Cancer Moonshot Summit in Washington, D.C.

Vice President Biden and Dr. Jill Biden will host a Cancer Moonshot Summit in Washington, D.C. at the White House. Cheryl Willman, MD, Director and CEO of The University of New Mexico Comprehensive Cancer Center, will attend.

25 Jun 2016

Oncogene signatures could help design new drug treatments for breast cancer

Drug treatments for breast cancer patients might soon be designed based on the unique genetic autograph of their tumor.

25 Jun 2016

Siemens Healthineers' new CT and MRI technologies to aid research across various common clinical pathways

The Transforming Outcomes and Health Economics Through Imaging (TOHETI) programme is looking to change the way medical imaging works by undertaking a range of pioneering research.

24 Jun 2016

Researchers identify new potential target for pancreatic cancer treatment

Using an innovative approach to identify a cancer's genetic vulnerabilities by more swiftly analyzing human tumors transplanted into mice, researchers have identified a new potential target for pancreatic cancer treatment, published online in Cell Reports.

24 Jun 2016

Mice study shows influence of dad's obesity on daughter’s body weight and breast cancer risk

Obese male mice and normal weight female mice produce female pups that are overweight at birth through childhood, and have delayed development of their breast tissue as well as increased rates of breast cancer.

24 Jun 2016

Taking ipilimumab, nivolumab drugs may increase risk of developing rheumatologic diseases

Case reports on 13 cancer patients suggest that a small number of cancer patients taking the immunotherapy drugs ipilimumab and nivolumab may be at some higher-than-normal risk of developing autoimmune joint and tissue diseases, including inflammatory arthritis, according to a preliminary study by Johns Hopkins Medicine researchers.

24 Jun 2016

Pre-operative MRI for breast cancer patients may need to be done in a different position

The difference in how a woman is positioned during MRI prior to breast conserving surgery and how she is positioned during the surgery distorts and displaces tumors while the surgery is being performed, report researchers.

23 Jun 2016

Pretreatment smoking linked to poor prognosis in AI-treated patients

Among older aromatase inhibitor (AI)-treated patients with breast cancer, current smokers at treatment initiation have an increased risk of breast cancer events and distant metastases, say Swedish researchers.

23 Jun 2016

HCC predictors identified for chronic HBV patients with newly diagnosed cirrhosis

In patients with chronic hepatitis B virus infection who have been newly diagnosed with cirrhosis, the risk of hepatocellular carcinoma development can be ascertained using several clinical and molecular factors, study findings indicate.

23 Jun 2016

Novel combination therapy slows cancer growth in patients with advanced solid tumors

A phase 1 clinical trial testing a novel combination therapy developed by scientists at VCU Massey Cancer Center slowed the growth of cancer in the majority of trial participants, which were patients with advanced solid tumors.

22 Jun 2016

Salvage inotuzumab ozogamicin improves ALL outcomes

Compared with standard chemotherapy, treatment with inotuzumab ozogamicin increases the rate of complete remission and allows a higher proportion of patients with relapsed or refractory acute lymphoblastic leukaemia to subsequently receive stem-cell transplantation, research suggests.

22 Jun 2016

Moffitt researchers develop mathematical model to show differences in subpopulations of tumors

Tumors are composed of many subpopulations of cells. A general consensus among scientists is that these subpopulations are due to random mutations. However, Moffitt Cancer Center researchers found that these assumptions may be incorrect.

22 Jun 2016

Oncology News and Research

Further Reading

Scientists develop computational method to map cancer progression

Vitamin D sufficiency linked to better pancreatic cancer survival

High levels of zinc may lead to kidney stone formation

New non-invasive method may help treat people with inoperable or hard-to-reach tumors

Cisplatin-based chemotherapy may lead to hearing loss in many testicular cancer survivors

Prognostic factor could help identify tumor recurrence after surgery for prostate cancer

NYU Lutheran helps patients fight prostate cancer with latest diagnostic and robotic surgery technology

Study highlights need to improve end-of-life care for all patients with serious illnesses

Vice President Biden to host Cancer Moonshot Summit in Washington, D.C.

Oncogene signatures could help design new drug treatments for breast cancer

Siemens Healthineers' new CT and MRI technologies to aid research across various common clinical pathways

Researchers identify new potential target for pancreatic cancer treatment

Mice study shows influence of dad's obesity on daughter’s body weight and breast cancer risk

Taking ipilimumab, nivolumab drugs may increase risk of developing rheumatologic diseases

Pre-operative MRI for breast cancer patients may need to be done in a different position

Pretreatment smoking linked to poor prognosis in AI-treated patients

HCC predictors identified for chronic HBV patients with newly diagnosed cirrhosis

Novel combination therapy slows cancer growth in patients with advanced solid tumors

Salvage inotuzumab ozogamicin improves ALL outcomes

Moffitt researchers develop mathematical model to show differences in subpopulations of tumors

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News